ABCB1 and neoplasm: These include the multidrug resistant efflux pump, MDR1/ABCB1, and the multidrug resistant-associated protein, MRP1, which are known to increase efflux of chemotherapeutic agents thereby allowing tumor (and normal) cells to evade drug-induced cytotoxicity [14, 15].